Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion. | J Immunother Cancer | 2025 | 40199608 | PubTator, text mining | PubMed |
| The Structural Biology of T-Cell Antigen Detection at Close Contacts. | Immunol Rev | 2025 | 40181535 | PubTator, text mining | PubMed |
| Early expansion of TIGIT+PD1+ effector memory CD4 T cells via agonistic effect of alefacept in new-onset type 1 diabetes. | J Immunol | 2025 | 40073269 | PubTator, text mining | PubMed |
| MYC networks associate with decreased CD8 T-cell presence in diffuse large B-cell lymphoma and may be addressed by the synergistic combination of AZD4573 and Selinexor - a preliminary analysis. | Ann Hematol | 2025 | 40064656 | PubTator, text mining | PubMed |
| Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma. | Blood Adv | 2025 | 40030008 | PubTator, text mining | PubMed |
| Cancer ATF4-mediated CD58 endocytosis impairs anti-tumor immunity and immunotherapy. | J Transl Med | 2025 | 40001116 | PubTator, text mining | PubMed |
| CD58 expression does not impact response to inotuzumab ozogamicin in patients with B-cell acute lymphoblastic leukemia. | EJHaem | 2025 | 39866945 | PubTator, text mining | PubMed |
| Challenges in Humoral Immune Response to Adeno-Associated Viruses Determination. | Int J Mol Sci | 2025 | 39859531 | PubTator, text mining | PubMed |
| Development and Validation of a Diagnostic Model for Stanford Type B Aortic Dissection Based on Proteomic Profiling. | J Inflamm Res | 2025 | 39816951 | PubTator, text mining | PubMed |
| Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity. | Cancer Commun (Lond) | 2025 | 39812166 | PubTator, text mining | PubMed |
| The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections. | Endocr Metab Immune Disord Drug Targets | 2025 | 39810445 | PubTator, text mining | PubMed |
| From structure prediction to function: defining the domain on the African swine fever virus CD2v protein required for binding to erythrocytes. | mBio | 2025 | 39688401 | PubTator, text mining | PubMed |
| CD38 and CD58: A Gallant Savior in Under-Resourced Laboratories. | Cureus | 2024 | 39634988 | PubTator, text mining | PubMed |
| CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa. | Proc Natl Acad Sci U S A | 2024 | 39560648 | PubTator, text mining | PubMed |
| Long-standing COVID-19 Disease in Immunocompromised and Immunocompetent Patients; Case Reports and Literature Review. | Iran J Allergy Asthma Immunol | 2024 | 39549298 | PubTator, text mining | PubMed |
| [Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | 39414605 | PubTator, text mining | PubMed |
| Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2. | Exp Mol Med | 2024 | 39349829 | PubTator, text mining | PubMed |
| Proteogenomic analysis integrated with electronic health records data reveals disease-associated variants in Black Americans. | J Clin Invest | 2024 | 39316441 | PubTator, text mining | PubMed |
| Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma. | J Blood Med | 2024 | 39279878 | PubTator, text mining | PubMed |
| VISION - an open-source software for automated multi-dimensional image analysis of cellular biophysics. | J Cell Sci | 2024 | 39258319 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=5